Thermo Fisher Scientific (TMO) Depreciation & Amortization (CF) (2009 - 2018)

Thermo Fisher Scientific (TMO) has reported Depreciation & Amortization (CF) for 10 consecutive years, with $558.0 million the latest figure, recorded in Q4 2018.

• For the quarter ending Q4 2018, Depreciation & Amortization (CF) fell 2.79% year-over-year to $558.0 million; the trailing twelve-month figure through Sep 2019 stood at $558.0 million (down 75.56% YoY), and the FY2018 full-year result was $2.3 billion, up 11.51% from the prior year.
• Depreciation & Amortization (CF) slipped to $558.0 million in Q4 2018 per TMO's latest filing, from $563.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $575.0 million in Q1 2018 and bottomed at $365.6 million in Q1 2014.
• Historically, Depreciation & Amortization (CF) has averaged $471.5 million across 5 years, with a median of $445.4 million in 2014.
• The sharpest annual moves came in 2014 and 2015: Depreciation & Amortization (CF) soared 81.99% in 2014, then slipped 6.14% in 2015.
• Over 5 years, Depreciation & Amortization (CF) stood at $428.7 million in 2014, then retreated by 1.03% to $424.3 million in 2015, then grew by 11.67% to $473.8 million in 2016, then increased by 21.15% to $574.0 million in 2017, then retreated by 2.79% to $558.0 million in 2018.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $558.0 million, $563.0 million, and $571.0 million for Q4 2018, Q3 2018, and Q2 2018 respectively.